Dashboard
Manage Tickers

ORMP ORAMED PHARMACEUTICALS INC.

Nasdaq oramed.com


$ 2.50 $ 0.09 (3.73 %)    

Friday, 21-Nov-2025 11:11:12 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 590.84 $ 3.56 (0.6 %)
DIA $ 464.42 $ 4.95 (1.08 %)
SPY $ 659.99 $ 4.99 (0.76 %)
TLT $ 89.31 $ -0.35 (-0.39 %)
GLD $ 375.56 $ 1.45 (0.39 %)
$ 2.42
$ 2.41
$ 2.49 x 300
$ 2.57 x 204
$ 2.47 - $ 2.50
$ 1.82 - $ 3.09
115,732
na
nm
$ 1.71
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 03-27-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-06-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-06-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 01-11-2022 11-30-2021 10-Q
17 11-24-2021 08-31-2021 10-K
18 07-14-2021 05-31-2021 10-Q
19 04-13-2021 02-28-2021 10-Q
20 01-14-2021 11-30-2020 10-Q
21 11-24-2020 08-31-2020 10-K
22 07-07-2020 05-31-2020 10-Q
23 04-06-2020 02-29-2020 10-Q
24 01-09-2020 11-30-2019 10-Q
25 11-27-2019 08-31-2019 10-K
26 07-10-2019 05-31-2019 10-Q
27 04-10-2019 02-28-2019 10-Q
28 01-14-2019 11-30-2018 10-Q
29 11-28-2018 08-31-2018 10-K
30 07-12-2018 05-31-2018 10-Q
31 04-09-2018 02-28-2018 10-Q
32 01-11-2018 11-30-2017 10-Q
33 11-29-2017 08-31-2017 10-K
34 07-06-2017 05-31-2017 10-Q
35 04-05-2017 02-28-2017 10-Q
36 01-11-2017 11-30-2016 10-Q
37 11-25-2016 08-31-2016 10-K
38 07-06-2016 05-31-2016 10-Q
39 04-06-2016 02-29-2016 10-Q
40 01-13-2016 11-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-november-13-2025-oramed-pharmaceuticals-q3-eps-126-beats-008-estimate-sales-2000m
Reported November 13, 2025: Oramed Pharmac...
11/17/2025 13:58:24

Oramed Pharmaceuticals (NASDAQ:ORMP) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate o...

oramed-advances-oral-insulin-program-independently-announces-launch-of-new-us-trial-company-reaffirms-commitment-to-rewarding-shareholders-including-plans-for-one-time-dividend
Oramed Advances Oral Insulin Program Indep...
10/23/2025 13:04:16

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
10/06/2025 21:06:27

Core News & Articles
Oramed Grants Scilex $27M Option To Repurc...
07/23/2025 13:47:25

As previously disclosed, on September 21, 2023, Oramed Pharmaceuticals Inc. (the "Company") entered into and consummate...

oramed-pharmaceuticals-extends-stock-buyback-program-for-one-year
Oramed Pharmaceuticals Extends Stock Buyba...
05/21/2025 21:00:09

-SEC Filing

Core News & Articles
Oramed Pharma Closes Strategic Investment ...
04/28/2025 13:04:26

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW))), the developer of the innovative ...

oramed-pharmaceuticals-issues-letter-to-shareholders-from-president-and-ceo-nadav-kidron
Oramed Pharmaceuticals Issues Letter To Sh...
03/04/2025 14:01:55

Dear Shareholders,I am happy to take this opportunity to provide our shareholders with an overview of our key accomplishments a...

congressional-trading-report-rep-brad-knott-sold-over-15k-in-oramed-pharmaceuticals-stock
Congressional Trading Report: Rep. Brad Kn...
02/26/2025 15:00:10

oramed-announces-entered-into-definitive-agremeents-to-spin-off-protein-oral-delivery-technology-into-joint-venture-with-hefei-tianhui-biotech
Oramed Announces Entered Into Definitive A...
02/11/2025 14:18:28

Core News & Articles
Scilex Announces Voluntary $13.2M Early Pa...
12/16/2024 14:09:53

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or the "Company"))), an innovative revenue-generating company foc...

Core News & Articles
Scilex Holding Company Announces Signing O...
10/07/2024 13:54:15

Affiliates of Murchinson, 3i LP, and existing senior debt holder, Oramed Pharmaceuticals, Inc. ("Oramed"), are expected...

hc-wainwright--co-reiterates-neutral-on-oramed-pharmaceuticals
HC Wainwright & Co. Reiterates Neutral on ...
09/09/2024 10:13:44

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Oramed Pharmaceuticals (NASDAQ:ORMP) with a Neutral.

oramed-pharmaceuticals-and-hefei-tianhui-biotech-finalize-joint-venture-jv-to-receive-capital-infusion-with-htit-committing-70m-in-cash-and-oramed-investing-25m-in-cash-and-stock
Oramed Pharmaceuticals And Hefei Tianhui B...
06/26/2024 13:15:18

oramed-pharmaceuticals-authorizes-20m-buyback
Oramed Pharmaceuticals Authorizes $20M Buy...
06/26/2024 13:09:55

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
06/12/2024 12:06:20

hc-wainwright--co-reiterates-neutral-on-oramed-pharmaceuticals
HC Wainwright & Co. Reiterates Neutral on ...
05/20/2024 11:21:51

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Oramed Pharmaceuticals (NASDAQ:ORMP) with a Neutral.

Core News & Articles
Compugen Appoints David Silberman As Its N...
05/15/2024 11:13:56

David will join Compugen from Oramed Pharmaceuticals Inc., where he served as Chief Financial Officer.

top-4-health-care-stocks-that-may-crash-this-quarter
Top 4 Health Care Stocks That May Crash Th...
02/02/2024 13:21:44

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a...

oramed-pharmaceuticals--parties-intend-for-jv-to-initiate-phase-3-oral-insulin-trial-in-the-us-oramed-will-be-entitled-to-receive-a-3-royalty-on-gross-revenues-of-jv-generated-from-oramed-related-assets
Oramed Pharmaceuticals Parties Intend For...
01/23/2024 21:51:35

oramed-pharmaceuticals-said-on-jan-22-co-and-unit-entered-into-joint-venture-agreement-with-hefei-tianhui-biotech-and-technowl-oramed-and-htit-will-initially-hold-equal-shares-in-jv-with-each-owning-50-of-equity
Oramed Pharmaceuticals Said On Jan 22, Co ...
01/23/2024 21:50:12

-8-K

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION